Meta-Analysis of 11 Heterogeneous Studies regarding Dipeptidyl Peptidase 4 Inhibitor Add-On Therapy for Type 2 Diabetes Mellitus Patients Treated with Insulin

BACKGROUND: Several clinical trials have addressed the therapeutic strategy of adding dipeptidyl peptidase 4 (DPP-4) inhibitors to the treatment of type 2 diabetes mellitus (DM) inadequately controlled by insulin therapy. However, there is a high degree of heterogeneity in these studies, and the cau...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibuki, Katsuya, Shimada, Shuji, Aoyama, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673952/
https://www.ncbi.nlm.nih.gov/pubmed/33224988
http://dx.doi.org/10.1155/2020/6321826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673952/
https://www.ncbi.nlm.nih.gov/pubmed/33224988
http://dx.doi.org/10.1155/2020/6321826

Ejemplares similares